Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Oct 15 - Oct 20
A virtual visit is required before prescribing
GLP-1 Receptor Agonist Market Key Players Novo Nordisk A/S (Ozempic, Wegovy, Rybelsus, Victoza, Saxenda) Eli Lilly and Company (Mounjaro, Zepbound, Trulicity) AstraZeneca PLC (Byetta, Bydureon BCise) Sanofi SA GlaxoSmithKline plc Pfizer Inc
Kemper, K
Some people may experience more noticeable results, while others may see more gradual changes
according to Real-World Safety Concerns of Tirzepatide: A Retrospective Analysis of FAERS Data, 23% of reports included nausea, a reminder that gastrointestinal upset is a common, clinically meaningful event
Another major drug in this class is tirzepatide, sold as Mounjaro and Zepbound
US$ 21.77
US$ 21.89
US$ 29.28
US$ 21.96
